Prostate Cancer - Results from #19540

Short-term androgen suppression and radiotherapy versus intermediate-term androgen suppression and radiotherapy, with or without zoledronic acid, in men with locally advanced prostate cancer (TROG 03.04 RADAR) - Abstract October 15, 2014

Abiraterone acetate for patients with metastatic castration-resistant prostate cancer progressing after chemotherapy: Final analysis of a multicentre, open-label, early-access protocol trial - Abstract October 14, 2014

A retrospective, Canadian multi-center study examining the impact of prior response to abiraterone acetate on efficacy of docetaxel in metastatic castration-resistant prostate cancer - Abstract October 14, 2014

Performance of serum prostate-specific antigen isoform [-2]proPSA (p2PSA) and the prostate health index (PHI) in a Chinese hospital-based biopsy population - Abstract October 14, 2014

Prostate cancer boost using high-dose-rate brachytherapy: Impact of the learning curve on the dosimetry - Abstract October 14, 2014

Early PSA level decline is an independent predictor of biochemical and clinical control for salvage postprostatectomy radiotherapy - Abstract October 14, 2014

Improving treatment strategies for patients with metastatic castrate resistant prostate cancer through personalized computational modeling - Abstract October 14, 2014

Long-term quality of life after radical prostatectomy: 8-Year longitudinal study in Japan - Abstract October 14, 2014

A systematic review of hypofractionation for primary management of prostate cancer - Abstract October 14, 2014

High dose versus conventional dose in external beam radiotherapy of prostate cancer: A meta-analysis of long-term follow-up - Abstract October 14, 2014

External beam radiotherapy plus single-fraction high dose rate brachytherapy in the treatment of locally advanced prostate cancer - Abstract October 14, 2014

Loose versus stranded seeds in permanent prostate brachytherapy: Dosimetric comparison of intraoperative plans - Abstract October 13, 2014

Salvage treatments following prostate radiation therapy: Role of the urologist - Abstract October 13, 2014

Prostate volume index and chronic inflammation of the prostate type IV with respect to the risk of prostate cancer - Abstract October 11, 2014

The length of a positive surgical margin is of prognostic significance in patients with clinically localized prostate cancer treated with radical prostatectomy - Abstract October 11, 2014

Clinical outcome of patients with lymph node-positive prostate cancer following radical prostatectomy and extended sentinel lymph node dissection - Abstract October 11, 2014

A global quality assurance system for personalized radiation therapy treatment planning for the prostate (or other sites) - Abstract October 11, 2014

Modifier 22 on perioperative outcomes of robotic assisted laparoscopic prostatectomy - Abstract October 11, 2014

Efficacy outcomes by baseline prostate-specific antigen quartile in the AFFIRM trial - Abstract October 11, 2014

How I do it: Managing bone health in patients with prostate cancer - Abstract October 10, 2014

Page 978 of 1436